Valuation: Psychemedics Corporation

Market Cap 9.79M 8.85M 8.17M 7.4M 13.96M 920M 14.38M 98.1M 38.98M 492M 36.75M 35.96M 1.57B P/E 2023
-4.09x
P/E 2024 -7x
Enterprise Value 9.54M 8.63M 7.96M 7.21M 13.6M 897M 14.01M 95.58M 37.99M 479M 35.81M 35.04M 1.53B EV / Sales 2023
0.79x
EV / Sales 2024 0.68x
Free-Float
44.15%
Yield 2023
2.36%
Yield 2024 -
1 week-3.61%
Current month-3.61%
1 month-3.61%
3 months-3.61%
6 months+7.62%
Current year+50.00%
Current year 1.33
Extreme 1.33
2.7
1 year 1.33
Extreme 1.33
2.7
3 years 1.11
Extreme 1.11
3.93
5 years 1.11
Extreme 1.11
8.9
10 years 1.11
Extreme 1.11
27.99
Manager TitleAgeSince
Chief Executive Officer 59 2023-08-16
Director of Finance/CFO 36 2023-11-26
Corporate Officer/Principal 40 2023-09-20
Director TitleAgeSince
Director/Board Member 64 2021-03-15
Director/Board Member 58 2022-04-03
Director/Board Member 64 2022-08-11
Date Insider Type Main position Quantity % Market Cap. Importance
12/13/24
Powell Anderson Capital Partners
BuyCompany 159,700 2.7093%
12/10/24
Powell Anderson Capital Partners
BuyCompany 86,991 1.4758%
12/10/24 Sell

Director

320,708 5.4408%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-3.61%+16.50%+2.13% 15.26M
+0.30%+10.40%+11.87%+32.67% 115B
-1.06%-1.34%+5.71%+115.04% 105B
+0.98%-11.22%+54.15%+590.93% 46.83B
-0.47%+2.74%+7.07%+112.82% 33.19B
+0.02%+2.48%+39.97%+81.81% 30.23B
+0.37%+1.93%+38.96%+95.49% 28.57B
-2.09%+0.14%+43.44%+433.30% 22.83B
+0.33%-1.02%-19.09%-18.10% 19.92B
+1.15%+2.99%-3.88%+34.18% 16.99B
Average -0.05%+0.45%+19.47%+148.03% 42B
Weighted average by Cap. -0.14%+1.72%+18.18%+149.54%

Financials

2023 2024
Net sales 22.1M 19.98M 18.45M 16.7M 31.51M 2.08B 32.45M 221M 87.99M 1.11B 82.94M 81.17M 3.53B 19.68M 17.8M 16.43M 14.87M 28.07M 1.85B 28.91M 197M 78.38M 989M 73.88M 72.3M 3.15B
Net income -4.15M -3.76M -3.47M -3.14M -5.92M -391M -6.1M -41.62M -16.54M -209M -15.59M -15.26M -665M -1.86M -1.68M -1.55M -1.41M -2.65M -175M -2.73M -18.65M -7.41M -93.53M -6.98M -6.84M -298M
Net Debt 334K 302K 279K 252K 476K 31.4M 490K 3.35M 1.33M 16.79M 1.25M 1.23M 53.43M -251K -227K -210K -190K -358K -23.6M -369K -2.51M -999K -12.61M -942K -922K -40.15M
Projected Income Statement - Annual - Psychemedics Corporation
Logo Psychemedics Corporation
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.
Employees
101
  1. Stock Market
  2. Stocks
  3. PMDI Stock